MX2021011310A - Recubrimientos para formas de dosificacion de residencia gastrica. - Google Patents

Recubrimientos para formas de dosificacion de residencia gastrica.

Info

Publication number
MX2021011310A
MX2021011310A MX2021011310A MX2021011310A MX2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A MX 2021011310 A MX2021011310 A MX 2021011310A
Authority
MX
Mexico
Prior art keywords
gastric residence
dosage forms
coatings
folded configuration
residence system
Prior art date
Application number
MX2021011310A
Other languages
English (en)
Spanish (es)
Inventor
Rosemary Kanasty
Tyler Grant
Erick Peeke
Nupura Bhise
David Altreuter
Marlene Schwarz
Sonia Holar
Original Assignee
Lyndra Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyndra Therapeutics Inc filed Critical Lyndra Therapeutics Inc
Publication of MX2021011310A publication Critical patent/MX2021011310A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/005—Coating of tablets or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
MX2021011310A 2019-03-20 2020-03-19 Recubrimientos para formas de dosificacion de residencia gastrica. MX2021011310A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962821361P 2019-03-20 2019-03-20
PCT/US2020/023710 WO2020191231A1 (en) 2019-03-20 2020-03-19 Coatings for gastric residence dosage forms

Publications (1)

Publication Number Publication Date
MX2021011310A true MX2021011310A (es) 2021-12-10

Family

ID=72519158

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021011310A MX2021011310A (es) 2019-03-20 2020-03-19 Recubrimientos para formas de dosificacion de residencia gastrica.

Country Status (10)

Country Link
US (1) US12582608B2 (cg-RX-API-DMAC7.html)
EP (1) EP3941444B1 (cg-RX-API-DMAC7.html)
JP (2) JP2022525482A (cg-RX-API-DMAC7.html)
CN (1) CN113840596A (cg-RX-API-DMAC7.html)
AU (1) AU2020242062B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021018424A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134186A1 (cg-RX-API-DMAC7.html)
IL (1) IL286510A (cg-RX-API-DMAC7.html)
MX (1) MX2021011310A (cg-RX-API-DMAC7.html)
WO (1) WO2020191231A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
IL286512B2 (en) 2019-03-20 2026-03-01 Lyndra Therapeutics Inc Capsules and capsule coatings for stomach-retaining dosage forms
CN113840596A (zh) 2019-03-20 2021-12-24 林德拉治疗公司 用于胃滞留剂型的衣层
CN116234540A (zh) 2020-07-29 2023-06-06 赛康特集团有限责任公司 具有包括交联聚(癸二酸甘油酯)的结构的形状引导控释和滞留
WO2024225479A1 (ja) * 2023-04-28 2024-10-31 クオリカプス株式会社 バンドシール液、バンドシール、ゼラチン硬質カプセルの封緘方法、及びゼラチン硬質カプセル製品

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9706149D0 (en) * 1997-03-25 1997-05-14 Scherer Corp R P Comestible capsules having flavoured coatings
US20050064027A1 (en) * 2001-12-15 2005-03-24 Spherics, Inc. Bioadhesive drug delivery system with enhanced gastric retention
PT1578350E (pt) 2002-03-26 2009-08-27 Euro Celtique Sa Composições revestidas com geles de libertação constante
IL166183A0 (en) 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
CN101232868A (zh) * 2005-04-19 2008-07-30 阿尔扎公司 曲马多和加巴喷丁的控释递药剂型
EP1901721A1 (en) 2005-06-23 2008-03-26 Spherics, Inc. Delayed release or extended-delayed release dosage forms of pramipexole
JP4948828B2 (ja) * 2005-11-28 2012-06-06 森下仁丹株式会社 胃内浮遊滞留シームレスカプセルとその製造方法
JP2009523175A (ja) * 2006-01-10 2009-06-18 パイペックス,インコーポレイテッド 目標とされる安定な銅状態を達成及び維持して銅関連中枢神経系疾患を予防及び治療するための医薬組成物及び方法
DK2997953T3 (en) * 2006-01-18 2019-04-15 Intec Pharma Ltd ADMINISTRATION ORAL ADMINISTRATION
WO2007093999A1 (en) * 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
KR20110042366A (ko) * 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
US8006033B2 (en) 2008-09-09 2011-08-23 Intel Corporation Systems, methods, and apparatuses for in-band data mask bit transmission
WO2010064139A2 (en) 2008-12-04 2010-06-10 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
US8414559B2 (en) 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
WO2011048494A2 (en) 2009-10-19 2011-04-28 Intec Pharma Ltd. Novel gastroretentive dosage forms of poorly soluble drugs
CN103402502A (zh) * 2011-02-14 2013-11-20 宝洁公司 包衣中包含蜂蜜的膜包衣固体剂型
EP3459570B1 (en) * 2012-08-29 2021-03-10 Cardiac Pacemakers, Inc. Enhanced low friction coating for medical leads and methods of making
US10485758B2 (en) 2014-06-02 2019-11-26 Clexio Biosciences Ltd. Expandable gastroretentive dosage form
MX2016016406A (es) 2014-06-11 2017-10-12 Massachusetts Inst Technology Estructuras de permanencia, y métodos relacionados.
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
WO2015195989A1 (en) * 2014-06-20 2015-12-23 Banner Life Sciences Llc Enteric soft capsule compositions
WO2016178971A1 (en) 2015-05-01 2016-11-10 Massachusetts Institute Of Technology Triggerable shape memory induction devices
EA201890068A1 (ru) 2015-06-17 2018-09-28 Байоджен Ма Инк. Частицы диметилфумарата и фармацевтические композиции на их основе
JPWO2017022248A1 (ja) * 2015-08-04 2018-05-24 富士カプセル株式会社 腸溶性カプセル
AU2016342374B2 (en) 2015-10-23 2022-08-04 Nortiva Bio, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
KR102796240B1 (ko) 2015-12-08 2025-04-16 린드라 테라퓨틱스 인코퍼레이티드 위 체류 시스템을 위한 기하 구성형태
US12109305B2 (en) 2016-05-27 2024-10-08 Lyndra Therapeutics, Inc. Materials architecture for gastric residence systems
EP3518902A4 (en) 2016-09-30 2020-07-08 Lyndra, Inc. GASTRIC RESIDENCE SYSTEMS FOR LONG-TERM ADMINISTRATION OF ADAMANTANE CLASS MEDICINES
ES2966736T3 (es) 2016-12-02 2024-04-24 Clexio Biosciences Ltd Sistema de residencia gástrica
TWI811221B (zh) 2017-06-09 2023-08-11 美商萊恩卓治療公司 具有釋放速率調節膜之胃的滯留系統
JP7288435B2 (ja) 2017-09-20 2023-06-07 リンドラ セラピューティクス, インコーポレイティド 胃内滞留システムのカプセル封入
CA3118056A1 (en) 2018-08-15 2020-02-20 Lyndra, Inc. Systems for enteric delivery of therapeutic agents
WO2020117855A1 (en) 2018-12-03 2020-06-11 Lyndra, Inc. Stomach simulating device
IL286512B2 (en) 2019-03-20 2026-03-01 Lyndra Therapeutics Inc Capsules and capsule coatings for stomach-retaining dosage forms
CN113840596A (zh) 2019-03-20 2021-12-24 林德拉治疗公司 用于胃滞留剂型的衣层
WO2021092486A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Formulations for release-rate modulating films for gastric residence systems
CA3160665A1 (en) 2019-11-08 2021-05-14 Lyndra Therapeutics, Inc. Gastric residence systems for administration of active agents
IL292848A (en) 2019-11-08 2022-07-01 Lyndra Therapeutics Inc Polymeric links for the gastric retention system
WO2021092484A1 (en) 2019-11-08 2021-05-14 Lyndra, Inc. Gastric residence systems having arms with controlled stiffness for improved gastric residence
EP4054538A4 (en) 2019-11-08 2024-02-07 Lyndra Therapeutics, Inc. STOMACH RESIDENCE SYSTEMS WITH A FILAMENT FOR IMPROVED STOMACH RESIDENCE
JP2024503485A (ja) 2021-01-19 2024-01-25 リンドラ セラピューティクス, インコーポレイティド リスペリドンを投与するための胃内滞留システム
AU2022270208A1 (en) 2021-05-05 2023-12-07 Lyndra Therapeutics, Inc. Gastric residence systems comprising methadone
EP4333823A4 (en) 2021-05-05 2025-04-09 Lyndra Therapeutics, Inc. Indwelling gastric sytems containing buprenorphine and naloxone
IL314378A (en) 2022-01-19 2024-09-01 Lyndra Therapeutics Inc Dosage forms for gastric preservation
EP4565274A2 (en) 2022-08-03 2025-06-11 Lyndra Therapeutics, Inc. Metal cores for gastric residence systems
JP2025531626A (ja) 2022-09-30 2025-09-22 リンドラ セラピューティクス, インコーポレイティド 胃内滞留システムを用いたリスペリドンの投与レジメン
WO2024249946A2 (en) 2023-06-02 2024-12-05 Lyndra Therapeutics, Inc. Manufacturing methods for gastric residence systems

Also Published As

Publication number Publication date
JP2022525482A (ja) 2022-05-16
BR112021018424A2 (pt) 2021-11-23
US20220192995A1 (en) 2022-06-23
IL286510A (en) 2021-10-31
AU2020242062B2 (en) 2025-12-11
EP3941444A4 (en) 2023-01-11
US12582608B2 (en) 2026-03-24
EP3941444B1 (en) 2025-03-26
EP3941444A1 (en) 2022-01-26
WO2020191231A1 (en) 2020-09-24
JP2025067914A (ja) 2025-04-24
AU2020242062A1 (en) 2021-11-11
CN113840596A (zh) 2021-12-24
CA3134186A1 (en) 2020-09-24

Similar Documents

Publication Publication Date Title
MX2025012985A (es) Capsulas y recubrimientos de capsulas para formas de dosificacion de residencia gastrica
BR112021018424A2 (pt) Revestimentos para formas de dosagem de residência gástrica
EP4054545A4 (en) Gastric residence systems for administration of active agents
CR20210368A (es) Combinación de dextrometorfano y bupropión para el tratamiento de depresión
WO2017171535A3 (en) Compositions
CN110869028A8 (zh) 治疗猫冠状病毒感染的方法
AR090898A1 (es) Una formulacion de farmaco de liberacion retardada
MX2021016109A (es) Metodos y composiciones particularmente para el tratamiento del trastorno por deficit de atencion.
EP4233902A3 (en) Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
NZ727659A (en) Residence structures and related methods
EP4464363A3 (en) Pharmaceutical dosage form for application to mucous membranes
NZ740615A (en) A pharmaceutical composition comprising electrohydrodynamically obtained fibres, the composition having improved residence time on the application site
TR201908994T4 (tr) Farmasötik bileşimler.
CO2017002682A2 (es) Composiciones y métodos para recubrimientos cannabinoides para uso en la entrega de fármacos
EP4281049A4 (en) GASTRIC RESIDENCE SYSTEMS FOR RISPERIDONE DELIVERY
MA50189A (fr) Formulations pharmaceutiques d'oligomère cyclique et d'abiratérone et procédés de formation et d'administration de celles-ci
EP3840735C0 (en) CAPSULE DEVICE FOR ADMINISTERING AN ACTIVE INGREDIENT TO THE DIGESTIVE TRACT
EA201170117A1 (ru) Противоаллергические биополимеры морского происхождения
BR112017002190A2 (pt) derivados de di-hidropteridinona e usos dos mesmos
WO2009106824A3 (en) Pharmaceutical formulations with a taste masking coating
MX2019001032A (es) Formulacion que tiene caracteristicas mejoradas de liberacion de farmacos ph dependientes, que contienen esomeprazol o una de sus sales farmaceuticas aceptable.
BR112021026025A2 (pt) Polímeros biodegradáveis ultrassensíveis ao ph
CY1121470T1 (el) Μια μορφοποιηση φαρμακου καθυστερημενης εκλυσης
JOP20210075A1 (ar) مشتقات 4-بيرازين-2-يل ميثيل-مورفولين واستخدامها كدواء
EA202191574A1 (ru) Лекарственный препарат для доставки лекарственного средства в толстую кишку